aprocitentan Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Idorsia Pharmaceuticals Ltd. (1)

Yes (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadhepatic impairment

I am/have/hadovarian failure

I am/have/hadrenal function test

I am/have/hadoophorectomy

I am/have/hadrenal function

I am/have/hadcirrhosis

I am/have/haddiastolic blood pressure

I am/have/hadmoderate hepatic insufficiency

I am/have/hadhysterectomy

I am/have/hadmoderate hepatic impairment

I am/have/hadsystolic blood pressure

I am/have/hadkidney function tests

I am/have/hadbilateral salpingectomy

I am/have/hadserum pregnancy test

I am/have/hadbody mass index

added new label for I am/have/had

more

I am looking for

I am looking foraprocitentan

I am looking forfollicle stimulating hormone

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

The Effect of Hepatic Impairment on Aprocitentan Pharmacokinetics

This is a prospective, single-center, open-label, single-dose, Phase 1 study, to assess the effect of moderate hepatic impairment due to liver cirrhosis on the pharmacokinetics of aprocitentan (ACT-132577).

follicle stimulating hormone

oophorectomy

renal function

diastolic blood pressure

moderate hepatic insufficiency

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.